ACADIA Pharmaceuticals Inc Defensive Interval Ratio
ACADIA Pharmaceuticals Inc defensive interval ratio. ACADIA Pharmaceuticals Inc (ACAD) has a Defensive Interval Ratio of 745 days as of June 2026. Defensive assets of $737.82 Million (cash $-, short-term investments $571.49 Million, receivables $166.33 Million) cover 745 days of daily cash needs of $990.24K/day. See ACAD current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of ACADIA Pharmaceuticals Inc (2002–2025)
Defensive interval ratio of ACADIA Pharmaceuticals Inc from 2002 to 2025. This chart shows how ACADIA Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 24 annual periods from 2002 to 2025. As of June 2026, the ratio stands at 745 days, meaning defensive assets of $737.82 Million can fund 745 days of operations without new revenue. Check ACADIA Pharmaceuticals Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
ACADIA Pharmaceuticals Inc Defensive Interval Ratio by Year (2002–2025)
ACADIA Pharmaceuticals Inc defensive interval ratio by year from 2002 to 2025. The table below presents the year-by-year Defensive Interval Ratio for ACADIA Pharmaceuticals Inc from 2002 to 2025, covering 24 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see ACADIA Pharmaceuticals Inc assets under control.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1041 days | $790.22 Million | $759.22K/day | $- | $641.99 Million | ▲ +541 days |
| 2024 | 500 days | $541.10 Million | $1.08 Million/day | $- | $436.40 Million | ▼ -6 days |
| 2023 | 506 days | $352.56 Million | $696.59K/day | $- | $250.21 Million | ▼ -554 days |
| 2022 | 1061 days | $365.06 Million | $344.19K/day | $- | $301.98 Million | ▼ -606 days |
| 2021 | 1666 days | $438.62 Million | $263.20K/day | $- | $373.27 Million | ▲ +440 days |
| 2020 | 1227 days | $356.21 Million | $290.32K/day | $- | $305.93 Million | ▼ -1435 days |
| 2019 | 2662 days | $545.62 Million | $205.00K/day | $- | $507.75 Million | ▲ +415 days |
| 2018 | 2246 days | $366.55 Million | $163.19K/day | $- | $338.76 Million | ▲ +85 days |
| 2017 | 2162 days | $290.35 Million | $134.33K/day | $- | $271.92 Million | ▼ -1032 days |
| 2016 | 3193 days | $372.56 Million | $116.67K/day | $- | $365.42 Million | ▲ +1283 days |
| 2015 | 1910 days | $114.63 Million | $60.01K/day | $- | $112.99 Million | ▼ -4120 days |
| 2014 | 6030 days | $261.60 Million | $43.38K/day | $- | $260.63 Million | ▼ -3074 days |
| 2013 | 9104 days | $174.08 Million | $19.12K/day | $- | $174.08 Million | ▲ +6032 days |
| 2012 | 3072 days | $50.07 Million | $16.30K/day | $- | $50.07 Million | ▲ +1642 days |
| 2011 | 1430 days | $24.16 Million | $16.89K/day | $- | $24.16 Million | ▼ -422 days |
| 2010 | 1852 days | $30.24 Million | $16.33K/day | $- | $30.24 Million | ▲ +1134 days |
| 2009 | 718 days | $28.94 Million | $40.29K/day | $- | $28.94 Million | ▼ -567 days |
| 2008 | 1285 days | $38.91 Million | $30.28K/day | $- | $38.91 Million | ▼ -794 days |
| 2007 | 2079 days | $109.87 Million | $52.84K/day | $- | $109.87 Million | ▲ +875 days |
| 2006 | 1205 days | $67.78 Million | $56.26K/day | $- | $67.78 Million | ▲ +646 days |
| 2005 | 558 days | $33.20 Million | $59.46K/day | $- | $33.20 Million | ▼ -608 days |
| 2004 | 1167 days | $27.63 Million | $23.67K/day | $- | $27.63 Million | ▲ +239 days |
| 2003 | 928 days | $20.91 Million | $22.54K/day | $- | $20.91 Million | ▲ +454 days |
| 2002 | 474 days | $7.99 Million | $16.86K/day | $- | $7.99 Million | — |